Results 41 to 50 of about 12,266 (176)

Malignancies in adult patients with common variable immunodeficiency

Revista Alergia México, 2015
Background: Common variable immunodeficiency (CVID) implies an increased risk of cancer, with an estimated incidence of 11-13%, particularly during the 5th and 6th decade of life.
Eunice Giselle López-Rocha, Karen Alicia Rodríguez-Mireles, Nora Hilda Segura-Méndez, Marco Antonio Yamazaki-Nakashimada   +3 more
doaj   +1 more source

Linfadenopatías generalizadas como manifestación inicial de lupus eritematoso sistémico: a propósito de un caso clínico

Revista Paraguaya de Reumatología, 2023
La presencia de linfadenopatías generalizadas se ha asociado de forma usual con lupus eritematoso sistémico (LES), sin embargo, no es usual encontrar este hallazgo como manifestación inicial de la enfermedad.
María Raad Sarabia, Gabriel Beltran Hoyos, Kewin Hernandez Pino, Jorge Acosta Buelva, Katty Chamorro Acevedo, Jorge Rico Fontalvo, Lourdes Carolina Vázquez Jiménez   +6 more
doaj   +1 more source

Shared Decision‐Making in Treatment Selection in Multiple Myeloma in Spain: The PRISMMA Study

European Journal of Haematology, Volume 116, Issue 2, Page 185-194, February 2026.
ABSTRACT Introduction Perceptions and experiences of shared decision‐making between patients and physicians in multiple myeloma (MM) care are not fully understood. A survey study was conducted to explore these perspectives in Spain. Methods Two anonymous online surveys, one for haematologists and one for MM patients, were developed.
Valentín Cabañas, María Casanova, Begoña Barragán, Isabel López, Anna Raya, Belén Santiago‐Josefat   +5 more
wiley   +1 more source

Experiencia en el uso de protocolos Biomed-2 para el estudio de reordenamientos de TCR e inmunoglobulinas en proliferaciones linfoides en el Instituto Nacional de Cancerología, Colombia

Biomédica: revista del Instituto Nacional de Salud, 2022
Introducción. El consorcio europeo BIOMED-2 se creó para determinar si una población linfoide de difícil clasificación patológica es clonal. En Colombia, la implementación de estas pruebas comenzó en el 2015 en el Instituto Nacional de Cancerología E.S.E.
Nicolás Villamizar-Rivera, Natalia Olaya   +1 more
doaj   +1 more source

Epigenetic reprogramming in multiple myeloma—Challenges and opportunities

International Journal of Cancer, Volume 158, Issue 2, Page 423-432, 15 January 2026.
Abstract In cancer, mutational processes act in concert with epigenetic reprogramming to endow malignant cells with hallmark properties that underpin tumorigenesis. Compared with the relatively rigid and slow processes of genetic evolution, the plastic nature of chromatin enables cells to adapt to a changing environment more rapidly.
Subhasree Kumar, Lev M. Kats, Emily Gruber   +2 more
wiley   +1 more source

Los linfomas

Oncología, 2022
Los linfomas son proliferaciones malignas de linfocitos B o T. Identifican dos tipos de neoplasias, la enfermedad de Hodgkin (EH) y los linfomas no Hodgkin (LNH). Durante las últimas décadas se han hecho importantes progresos en la compresión de sus patogénesis, la cual está ritmada por transolcaciones cromosómicas que se presentan en el desarrollo de ...
openaire   +1 more source

Increased risk of secondary malignancies after autologous transplantation in R/R follicular lymphoma: Long‐term results from FIL‐FLAZ12 Phase III trial

HemaSphere, Volume 10, Issue 8, August 2026.
Rita Tavarozzi, Andrea Evangelista, Manuela Zanni, Chiara Consoli, Alessandra Tucci, Barbara Botto, Silvia Bolis, Pietro Lauzzana, Vittorio Ruggero Zilioli, Benedetta Puccini, Annalisa Arcari, Vincenzo Pavone, Gloria Margiotta‐Casaluci, Monica Tani, Federica Cavallo, Antonio Pinto, Chiara Ghiggi, Domenico Pastore, Paolo Corradini, Andrés José María Ferreri, Angelo Palmas, Caterina Patti, Francesca Re, Fabio Benedetti, Giuseppe Milone, Stefano Luminari, Elsa Pennese, Elisa Bossi, Carola Boccomini, Antonella Anastasia, Chiara Bottelli, Donato Mannina, Samantha Pozzi, Catello Califano, Luca Arcaini, Flavio Falcinelli, Giuseppe Pietrantuono, Ilaria Del Giudice, Sara Usai, Jacopo Olivieri, Filippo Gherlinzoni, Attilio Olivieri, Tommasina Perrone, Fabrizio Pomponi, Giovannino Ciccone, Umberto Vitolo, Marco Ladetto   +46 more
wiley   +1 more source

CARACTERIZAÇÃO DOS CASOS DE LINFOMA NA REGIÃO METROPOLITANA DO RIO DE JANEIRO: UMA COMPARAÇÃO ENTRE PESSOAS VIVENDO COM HIV E POPULAÇÃO GERAL

Hematology, Transfusion and Cell Therapy
Introdução: O vírus da imunodeficiência humana (HIV) é carcinogênico em humanos, tanto por ação viral direta quanto por imunossupressão, desregulação imune e estimulação antigênica crônica, o que favorece o desenvolvimento de neoplasias.
Mario Gustavo de Aranda PACHECO, Beatriz Mutz ALBANO, Carolina EMERICK, Jacob Richard MILNOR, Mariana Coutinho STUDART, Josuelma Liberatori Fernandes ALVES, Luciana Wernersbach PINTO, Fabio Eudes LEAL   +7 more
doaj   +1 more source

Extracorporeal Cytokine Hemadsorption for the Treatment of Severe Steroid Refractory Cytokine Release Syndrome Secondary to T‐Cell Immunotherapy for B‐Cell Malignancies: A Case Series

Hematological Oncology, Volume 44, Issue 4, July 2026.
Gianluca Cavallaro, Silvia Ferrari, Anna Pollastri, Elena Di Credico, Cristian Meli, Monica Rondi, Alessandro Putelli, Federico Lussana, Anna Grassi, Alessandro Rambaldi, Tino Martino Valetti, Ivano Riva, Giuseppe Gritti   +12 more
wiley   +1 more source

Quality of Life and Needs of Patients Undergoing CAR‐T Cell Therapy: The Patients’ Perspective

European Journal of Cancer Care, Volume 2026, Issue 1, 2026.
Background Despite the strong emphasis in recent scientific literature on the pharmacological features of CAR‐T cells, patients’ quality of life (QoL) and needs, by contrast, have received little attention. Aim This study aims to investigate patients’ perspectives on their QoL and needs in a referral centre for CAR‐T cell treatment in Italy.
S. Alfieri, E. Criscuolo, A. Chiappella, M. Bosisio, R. Petrigliano, L. Gangeri, B. Scacciati, N. Pozzetto, M. Cani, C. Borreani, Divakar Sharma   +10 more
wiley   +1 more source